According to TechFlow news on July 8, reported by The Block, Nasdaq-listed medical technology company BioSig Technologies (BSGM) announced on Monday that it has reached a financing agreement of up to $1.1 billion with an undisclosed institutional investor to promote the on-chain transformation of the commodity market. This financing includes $100 million in senior secured convertible bonds and a $1 billion equity line of credit. This financing follows BioSig's merger with Bahamian company Streamex Exchange Corporation, marking a strategic shift towards the tokenization of real-world assets. BioSig CEO and Streamex co-founder Henry McPhie stated that the company's mission is to provide liquidity, transparency, and accessibility to a $142 trillion commodity market.